loader image
Monday, December 22, 2025
73.1 F
McAllen
- Advertisement -

Have Researchers Just Found Another Cause of Parkinson’s Disease?

Translate to Spanish or other 102 languages!

New research suggests another potential biomarker and trigger for Parkinson’s disease. Image for illustration purposes
New research suggests another potential biomarker and trigger for Parkinson’s disease. Image for illustration purposes

Medical News Today

- Advertisement -
  • Researchers from the University of Copenhagen, in Denmark, have made an important breakthrough in our understanding of Parkinson’s disease.
  • Their discovery centres around the damage of mitochondrial DNA in brain cells and its potential as an early biomarker for the disease.
  • As this condition affects over 10 million individuals worldwide, these findings hold significant promise for the future of diagnostics and treatments.
  • With the implications of these damaged DNA pieces likened to an unchecked forest blaze, the research provides hope and a fresh direction in understanding and treating this condition.

Parkinson’s disease is a neurological condition that impacts movement. Initial symptoms involve shaking, diminished sense of smell and difficulties with coordination.

Follow the link below to Medical News Today to read the full story:

https://www.medicalnewstoday.com/articles/have-researchers-just-found-another-cause-of-parkinsons-disease

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves Daily Pill to Treat Low Libido in Women After Menopause

On December 15, 2025, the U.S. Food and Drug Administration (FDA) approved the medication Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65.

Heart Association Highlights 2025’s Major Research Findings

In 2025, cardiovascular investigators worldwide reported findings that could help fill important gaps in preventing and managing conditions including high blood pressure, stroke, heart failure, dangerous blood clots and aortic stenosis.

DHR Health and Brownsville Join Forces on Major Hospital Expansion

The City of Brownsville and DHR Health announced a new public-private partnership to expand DHR Health Brownsville, marking a major investment in local healthcare and economic development

Uniting Experts to Revolutionize Cancer Treatment

More than 70% of all cancers are impacted by mutations caused by a group of DNA-editing enzymes that drives tumor growth and drug resistance. The apolipoprotein B mRNA-editing enzyme catalytic polypeptide, or APOBEC, family, is a dominant factor in many cancers including bladder, breast, cervical, head and neck and lung.
- Advertisement -
×